Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Identifying gene-environment interactions in schizophrenia: contemporary challenges for integrated, large-scale investigations.
Schizophr Bull. 2014 Jul;40(4):729-36. doi: 10.1093/schbul/sbu069. Epub 2014 May 24.
Schizophr Bull. 2014.
PMID: 24860087
Free PMC article.
Review.
Premorbid Adjustment and IQ in Patients With First-Episode Psychosis: A Multisite Case-Control Study of Their Relationship With Cannabis Use.
Ferraro L, La Cascia C, Quattrone D, Sideli L, Matranga D, Capuccio V, Tripoli G, Gayer-Anderson C, Morgan C, Sami MB, Sham P, de Haan L, Velthorst E, Jongsma HE, Kirkbride JB, Rutten BPF, Richards AL, Roldan L, Arango C, Bernardo M, Bobes J, Sanjuan J, Santos JL, Arrojo M, Tarricone I, Tortelli A, Szöke A, Del-Ben CM, Selten JP, Lynskey M, Jones PB, Van Os J, La Barbera D; WP2 EU-GEI GROUP; Murray RM, Di Forti M.
Ferraro L, et al.
Schizophr Bull. 2020 Apr 10;46(3):517-529. doi: 10.1093/schbul/sbz077.
Schizophr Bull. 2020.
PMID: 31361020
Free PMC article.
Item in Clipboard
The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study.
Di Forti M, Quattrone D, Freeman TP, Tripoli G, Gayer-Anderson C, Quigley H, Rodriguez V, Jongsma HE, Ferraro L, La Cascia C, La Barbera D, Tarricone I, Berardi D, Szöke A, Arango C, Tortelli A, Velthorst E, Bernardo M, Del-Ben CM, Menezes PR, Selten JP, Jones PB, Kirkbride JB, Rutten BP, de Haan L, Sham PC, van Os J, Lewis CM, Lynskey M, Morgan C, Murray RM; EU-GEI WP2 Group.
Di Forti M, et al.
Lancet Psychiatry. 2019 May;6(5):427-436. doi: 10.1016/S2215-0366(19)30048-3. Epub 2019 Mar 19.
Lancet Psychiatry. 2019.
PMID: 30902669
Free PMC article.
Item in Clipboard
Olanzapine in treatment-refractory schizophrenia: results of an open-label study. The Spanish Group for the Study of Olanzapine in Treatment-Refractory Schizophrenia.
Martín J, Gómez JC, García-Bernardo E, Cuesta M, Alvarez E, Gurpegui M.
Martín J, et al. Among authors: garcia bernardo e.
J Clin Psychiatry. 1997 Nov;58(11):479-83.
J Clin Psychiatry. 1997.
PMID: 9413413
Clinical Trial.
Item in Clipboard
Pharmacoeconomic assessment of olanzapine in the treatment of refractory schizophrenia based on a pilot clinical study.
Sacristán JA, Gómez JC, Martín J, García-Bernardo E, Peralta V, Alvarez E, Gurpegui M; Spanish Group for the Study of Olanzapine in Treatment-Refractory Schizophrenia.
Sacristán JA, et al. Among authors: garcia bernardo e.
Clin Drug Investig. 1998;15(1):29-35. doi: 10.2165/00044011-199815010-00004.
Clin Drug Investig. 1998.
PMID: 18370463
Item in Clipboard
A Pharmacovigilance Study in First Episode of Psychosis: Psychopharmacological Interventions and Safety Profiles in the PEPs Project.
Bioque M, Llerena A, Cabrera B, Mezquida G, Lobo A, González-Pinto A, Díaz-Caneja CM, Corripio I, Aguilar EJ, Bulbena A, Castro-Fornieles J, Vieta E, Lafuente A, Mas S, Parellada M, Saiz-Ruiz J, Cuesta MJ, Bernardo M; PEPs GROUP.
Bioque M, et al.
Int J Neuropsychopharmacol. 2016 Mar 31;19(4):pyv121. doi: 10.1093/ijnp/pyv121. Print 2016 Apr.
Int J Neuropsychopharmacol. 2016.
PMID: 26506856
Free PMC article.
Item in Clipboard
Cite
Cite